-
2
-
-
67349241946
-
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
-
R. Ponce, L. Abad, L. Amaravadi, T. Gelzleichter, E. Gore, J. Green, S. Gupta, D. Herzyk, C. Hurst, I.A. Ivens, T. Kawabata, C. Maier, B. Mounho, B. Rup, G. Shankar, H. Smith, P. Thomas, and D. Wierda Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies Regul. Toxicol. Pharmacol. 54 2009 164 182
-
(2009)
Regul. Toxicol. Pharmacol.
, vol.54
, pp. 164-182
-
-
Ponce, R.1
Abad, L.2
Amaravadi, L.3
Gelzleichter, T.4
Gore, E.5
Green, J.6
Gupta, S.7
Herzyk, D.8
Hurst, C.9
Ivens, I.A.10
Kawabata, T.11
Maier, C.12
Mounho, B.13
Rup, B.14
Shankar, G.15
Smith, H.16
Thomas, P.17
Wierda, D.18
-
3
-
-
58249116651
-
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
-
G. Shankar, V. Devanarayan, L. Amaravadi, Y.C. Barrett, R. Bowsher, D. Finco-Kent, M. Fiscella, B. Gorovits, S. Kirschner, M. Moxness, T. Parish, V. Quarmby, H. Smith, W. Smith, L.A. Zuckerman, and E. Koren Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products J. Pharm. Biomed. Anal. 48 2008 1267 1281
-
(2008)
J. Pharm. Biomed. Anal.
, vol.48
, pp. 1267-1281
-
-
Shankar, G.1
Devanarayan, V.2
Amaravadi, L.3
Barrett, Y.C.4
Bowsher, R.5
Finco-Kent, D.6
Fiscella, M.7
Gorovits, B.8
Kirschner, S.9
Moxness, M.10
Parish, T.11
Quarmby, V.12
Smith, H.13
Smith, W.14
Zuckerman, L.A.15
Koren, E.16
-
4
-
-
69249203868
-
Immunogenicity assessment of therapeutic proteins and peptides
-
A. Kaliyaperumal, and S. Jing Immunogenicity assessment of therapeutic proteins and peptides Curr. Pharm. Biotechnol. 10 2009 352 358
-
(2009)
Curr. Pharm. Biotechnol.
, vol.10
, pp. 352-358
-
-
Kaliyaperumal, A.1
Jing, S.2
-
5
-
-
77349117260
-
Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies
-
K. Stubenrauch, U. Wessels, U. Essig, R. Vogel, and J. Schleypen Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies J. Pharm. Biomed. Anal. 52 2010 249 254
-
(2010)
J. Pharm. Biomed. Anal.
, vol.52
, pp. 249-254
-
-
Stubenrauch, K.1
Wessels, U.2
Essig, U.3
Vogel, R.4
Schleypen, J.5
-
6
-
-
3142534409
-
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products
-
A.R. Mire-Sluis, Y.C. Barrett, V. Devanarayan, E. Koren, H. Liu, M. Maia, T. Parish, G. Scott, G. Shankar, E. Shores, S.J. Swanson, G. Taniguchi, D. Wierda, and L.A. Zuckerman Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products J. Immunol. Methods 289 2004 1455 1460
-
(2004)
J. Immunol. Methods
, vol.289
, pp. 1455-1460
-
-
Mire-Sluis, A.R.1
Barrett, Y.C.2
Devanarayan, V.3
Koren, E.4
Liu, H.5
Maia, M.6
Parish, T.7
Scott, G.8
Shankar, G.9
Shores, E.10
Swanson, S.J.11
Taniguchi, G.12
Wierda, D.13
Zuckerman, L.A.14
-
7
-
-
41349116947
-
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
-
E. Koren, H.W. Smith, E. Shores, G. Shankar, D. Finco-Kent, B. Rup, Y.C. Barrett, V. Devanarayan, B. Gorovits, S. Gupta, T. Parish, V. Quarmby, M. Moxness, S.J. Swanson, G. Taniguchi, L.A. Zuckerman, C.C. Stebbins, and A. Mire-Sluis Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products J. Immunol. Methods 333 2008 1 9
-
(2008)
J. Immunol. Methods
, vol.333
, pp. 1-9
-
-
Koren, E.1
Smith, H.W.2
Shores, E.3
Shankar, G.4
Finco-Kent, D.5
Rup, B.6
Barrett, Y.C.7
Devanarayan, V.8
Gorovits, B.9
Gupta, S.10
Parish, T.11
Quarmby, V.12
Moxness, M.13
Swanson, S.J.14
Taniguchi, G.15
Zuckerman, L.A.16
Stebbins, C.C.17
Mire-Sluis, A.18
-
8
-
-
0019739585
-
Preparation of monoclonal antibodies: Strategies and procedures
-
G. Galfré, and C. Milstein Preparation of monoclonal antibodies: strategies and procedures Methods Enzymol. 73 1981 3 46
-
(1981)
Methods Enzymol.
, vol.73
, pp. 3-46
-
-
Galfré, G.1
Milstein, C.2
-
9
-
-
0022556044
-
Purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel blue chromatography
-
C. Bruck, J.A. Drebin, C. Glineur, and D. Portetelle Purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel blue chromatography Methods Enzymol. 121 1986 587 596
-
(1986)
Methods Enzymol.
, vol.121
, pp. 587-596
-
-
Bruck, C.1
Drebin, J.A.2
Glineur, C.3
Portetelle, D.4
-
10
-
-
33845364560
-
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: Potential application in humorally mediated autoimmune disease
-
S.B. Petkova, S. Akilesh, T.J. Sproule, G.J. Christianson, H. Al Khabbaz, A.C. Brown, L.G. Presta, Y.G. Meng, and D.C. Roopenian Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease Int. Immunol. 18 2006 1759 1769
-
(2006)
Int. Immunol.
, vol.18
, pp. 1759-1769
-
-
Petkova, S.B.1
Akilesh, S.2
Sproule, T.J.3
Christianson, G.J.4
Al Khabbaz, H.5
Brown, A.C.6
Presta, L.G.7
Meng, Y.G.8
Roopenian, D.C.9
-
11
-
-
8644240039
-
Antibody-cytokine fusion proteins: Innovative weapons in the war against cancer
-
J.S. Dela Cruz, T.H. Huang, M.L. Penichet, and S.L. Morrison Antibody-cytokine fusion proteins: innovative weapons in the war against cancer Clin. Exp. Med. 4 2004 57 64
-
(2004)
Clin. Exp. Med.
, vol.4
, pp. 57-64
-
-
Dela Cruz, J.S.1
Huang, T.H.2
Penichet, M.L.3
Morrison, S.L.4
|